Leading international law firm Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (02315.HK)’s listing on the Main Board of the Hong Kong Stock Exchange. Biocytogen listed on 1 September 2022. The company focuses on biopharmaceutical research and development, pre-clinical research […]
The post Herbert Smith Freehills Advises Sponsors On Biocytogen Pharmaceuticals’ Hong Kong Ipo appeared first on Legal Desire.